Zinc acetate

Generic Name: Zinc acetate

Brand Names: Banophen, Benadryl Itch Stopping, Caladryl Clear, Derma Gran, Galzin, Wal-dryl

Drug Type: Small Molecule

Chemical Formula: C_₄H_₆O_₄Zn

CAS Number: 557-34-6

Unique Ingredient Identifier: H2ZEY72PME

Indication: Zinc can be used for the treatment and prevention of zinc deficiency/its consequences, including stunted growth and acute diarrhea in children, and slowed wound healing. It is also utilized for boosting the immune system, treating the common cold and recurrent ear infections, as well as preventing lower respiratory tract infections .

Associated Conditions: Pruritus, Skin Irritation, Oozing and weeping, Pain and itching

Associated Therapies: -

Clinical Trials

Prospective Pilot Trial to Address Feasibility and Safety of Oral Zinc in GNAO1 Associated Disorders

Phase 2

Not yet recruiting

Conditions: Dystonia
GNAO1
Epilepsy
Development Delay
Developmental and Epileptic Encephalopathy 17
Neurodevelopmental Disorder With Involuntary Movements
Choreoathetosis

Interventions: Drug: Zinc Acetate Dihydrate

First Posted Date: 2024-05-14

Last Posted Date: 2024-05-14

Lead Sponsor: Children's University Hospital Cologne, Germany

Target Recruit Count: 12

Registration Number: NCT06412653

Locations: 🇩🇪
Children's Hospital, University Hospital Cologne, University of Cologne, Cologne, Germany

Effect of Oral Vitamin C in Assessing the Severity of Oral Mucositis in Chemoradiation of Head and Neck Cancers

Phase 2

Completed

Conditions: Oral Mucositis

Interventions: Drug: Ascorbic Acid
Drug: Zinc acetate

First Posted Date: 2016-08-16

Last Posted Date: 2019-03-20

Lead Sponsor: Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre

Target Recruit Count: 180

Registration Number: NCT02868151

Locations: 🇮🇳
MNJ institute of oncology & regional cancer center, Hyderabad, Telangana, India

The Impact of Zinc Supplementation on Left Ventricular Function in Nonischemic Cardiomyopathy

Phase 1

Completed

Conditions: Heart Failure
Cardiomyopathies

Interventions: Drug: Zinc Acetate

First Posted Date: 2008-06-12

Last Posted Date: 2017-11-06

Lead Sponsor: University of Michigan

Target Recruit Count: 48

Registration Number: NCT00696410

Locations: 🇺🇸
University of Michigan Health System, Ann Arbor, Michigan, United States

The Efficacy of Zinc as Adjunct Therapy in the Treatment of Severe Pneumonia in Children

Phase 3

Completed

Conditions: Pneumonia

Interventions: Drug: Zinc acetate
Drug: Placebo

First Posted Date: 2006-09-07

Last Posted Date: 2009-07-07

Lead Sponsor: Makerere University

Target Recruit Count: 328

Registration Number: NCT00373100

Locations: 🇺🇬
Department of Paediatrics and Child Health, Makerere University, Kampala, Uganda

Efficacy and Safety Study of Zinc Acetate to Treat Wilson's Disease in Japan.

Phase 3

Completed

Conditions: Wison's Disease

First Posted Date: 2005-09-21

Last Posted Date: 2010-09-10

Lead Sponsor: Nobelpharma

Registration Number: NCT00212368

Study of Zinc for Wilson Disease

Phase 4

Completed

Conditions: Wilson Disease

First Posted Date: 1999-10-19

Last Posted Date: 2005-06-24

Lead Sponsor: National Center for Research Resources (NCRR)

Target Recruit Count: 300

Registration Number: NCT00004338

Locations: 🇺🇸
University of Michigan Health Systems, Ann Arbor, Michigan, United States

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy